Familywise error rate control for block response-adaptive randomization.

Stat Methods Med Res

MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.

Published: June 2023

Response-adaptive randomization allows the probabilities of allocating patients to treatments in a clinical trial to change based on the previously observed response data, in order to achieve different experimental goals. One concern over the use of such designs in practice, particularly from a regulatory viewpoint, is controlling the type I error rate. To address this, Robertson and Wason (Biometrics, 2019) proposed methodology that guarantees familywise error rate control for a large class of response-adaptive designs by re-weighting the usual -test statistic. In this article, we propose an improvement of their method that is conceptually simpler, in the context where patients are allocated to the experimental treatment arms in a trial in blocks (i.e. groups) using response-adaptive randomization. We show the modified method guarantees that there will never be negative weights for the contribution of each block of data to the adjusted test statistics, and can also provide a substantial power advantage in practice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394397PMC
http://dx.doi.org/10.1177/09622802231167437DOI Listing

Publication Analysis

Top Keywords

error rate
12
response-adaptive randomization
12
familywise error
8
rate control
8
control block
4
response-adaptive
4
block response-adaptive
4
randomization response-adaptive
4
randomization allows
4
allows probabilities
4

Similar Publications

Background: Currently, there is a dearth of systematic research data on the phenomenon of false-positive reactions in treponemal tests. The aim of this study is to analyze the clinical characteristics and influencing factors associated with false-positive treponemal tests in patients, so as to enhance the diagnostic accuracy of syphilis and mitigate misdiagnosis-induced incorrect treatment.

Methods: From January 2017 to December 2023, a total of 759 cases with false-positive results for treponema were screened for blood transfusion, surgery, or other medical interventions at Jinling hospital.

View Article and Find Full Text PDF

Investigating BoLA Class II DRB3*009:02 carrying cattle in Japan.

Vet Anim Sci

March 2025

Veterinary Virology, School of Veterinary Medicine, Rakuno Gakuen University, 582 Midorimachi Bunkyodai, Ebetsu, Hokkaido, 0698501, Japan.

Enzootic bovine leukosis (EBL) is a malignant lymphoma of cattle that is mainly caused by bovine leukemia virus (BLV) infection. In this study, PCR-RFLP was used to investigate the frequency of the DRB3*009:02 allele in several farms with different herd management practices in Japan. A total of 742 Holsteins (384) and Japanese Blacks (230) were used as the sample size for the study, which was larger than the number of cattle in the study area with a confidence level of 95 % and a margin of error of 8.

View Article and Find Full Text PDF

Motivation: Missing values are prevalent in high-throughput measurements due to various experimental or analytical reasons. Imputation, the process of replacing missing values in a dataset with estimated values, plays an important role in multivariate and machine learning analyses. The three missingness patterns, including missing completely at random, missing at random, and missing not at random, describe unique dependencies between the missing and observed data.

View Article and Find Full Text PDF

With the continuous advancement of medical treatments, there is an increasing demand for clinical trial designs and analyses using cure rate models to accommodate a plateau in the survival curve. This is especially pertinent in oncology, where high proportions of patients, such as those with melanoma, lung cancer, and endometrial cancer, exhibit usual life spans post-cancer detection. A Bayesian clinical trial design methodology for multivariate time-to-event outcomes with cured fractions is developed.

View Article and Find Full Text PDF

To adjust, or not to adjust, for multiple comparisons.

J Clin Epidemiol

January 2025

Wolfson Institute of Population Health, Queen Mary University of London, London, UK. Electronic address:

Questions often arise concerning when, whether and how we should adjust our interpretation of the results from multiple hypothesis tests. Strong arguments have been put forward in the epidemiological literature against any correction or adjustment for multiplicity, but regulatory requirements (particularly for pharmaceutical trials) can sometimes trump other concerns. The formal basis for adjustment is often the control of error rates, and hence the problems of multiplicity may seem rooted in a purely frequentist paradigm, though this can be a restrictive viewpoint.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!